Improving recruitment, efficiency and quality of academic cancer clinical trials in Canada
Access
- Bringing high-quality trial options to underserved communities by engaging local care providers and enabling decentralized trial delivery
Outcomes
- Efficient delivery of cancer clinical trials
- 40,000+ patients recruited to academic cancer clinical trials (ACCTs)
Impact
- 850+ ACCTS
- 400+ trial publications
- 70+ practice changing trials
Network Tools & Resources
3CTN Reports
News & Events
-
impACCT Virtual Rounds Spring Session 2026
Date: Tuesday, June 9, 2026 Time: 12:00 p.m. – 1:00 p.m. EDT Location: Virtual Event Facilitator: Carol Hill, Chair of Patient Representative Advisory Sub-Committee Session #1 Trial #1: (BCC) CHRONO-RCC – Time-of-day–dependent administration of dual immune check point inhibitors (ICI) in advanced kidney cancer (NCT07338981) Trial #2: (BCC) CHRONO-EVP – Time-of-day dependent administration of…
-
EDGE Essentials May 2026
This edition highlights the newly released EDGE Grant Management module, introducing a more flexible way to track grants independently from projects. You’ll also find training resources and drop-in support, our Tip of the Month on using filters effectively, answers to a common FAQ, and a preview of upcoming EDGE enhancements.
-
EDGE Essentials April 2026
3CTN presents the EDGE essentials newsletter which covers recent updates, tips and tricks and FAQs. Be sure to register to receive future newsletter releases.
Our Partners
Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.
Funding Partners
Collaborators
